TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News FDA approves Amgen’s BLINCYTO for expanded use in B-ALL treatment Amgen (NASDAQ: AMGN) has achieved a significant milestone with the recent U.S. Food and Drug Administration (FDA) approval… byPallavi MadhirajuJune 16, 2024